BAX
Baxter International Inc.

2,637
Mkt Cap
$13.85B
Volume
3,276.00
52W High
$37.74
52W Low
$17.40
PE Ratio
-38.11
BAX Fundamentals
Price
$19.87
Prev Close
$20.07
Open
$19.89
50D MA
$19.28
Beta
0.77
Avg. Volume
8.94M
EPS (Annual)
-$1.27
P/B
1.41
Rev/Employee
$279,894.74
Loading...
Loading...
News
all
press releases
Greenhaven Associates Inc. Takes Position in Baxter International Inc. $BAX
Greenhaven Associates Inc. purchased a new stake in Baxter International Inc. (NYSE:BAX - Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Reasons to Retain Baxter International Stock in Your Portfolio Now
BAX is reshaping its portfolio following the divestiture of its Kidney Care business, focusing on surgical strength, deleveraging and tighter execution to rebuild momentum.
Zacks·6d ago
News Placeholder
AVNS & Siemens Healthineers Team Up on Advanced Integrated Pain Care
Avanos Medical teams up with an imaging partner to pair RFA with mobile imaging, targeting the shift of complex pain procedures to outpatient care.
Zacks·8d ago
News Placeholder
Baxter International Inc. $BAX Shares Purchased by Cooke & Bieler LP
Cooke & Bieler LP boosted its holdings in Baxter International Inc. (NYSE:BAX - Free Report) by 25.7% during the third quarter, according to the company in its most recent filing with the Securities...
MarketBeat·8d ago
News Placeholder
Stoneridge Investment Partners LLC Buys Shares of 93,458 Baxter International Inc. $BAX
Stoneridge Investment Partners LLC purchased a new stake in Baxter International Inc. (NYSE:BAX - Free Report) in the third quarter, according to the company in its most recent 13F filing with the...
MarketBeat·9d ago
News Placeholder
Zacks Research Issues Optimistic Forecast for BAX Earnings
Baxter International Inc. (NYSE:BAX - Free Report) - Equities research analysts at Zacks Research raised their Q3 2027 earnings estimates for shares of Baxter International in a report issued on...
MarketBeat·11d ago
News Placeholder
Baxter International Inc. (NYSE:BAX) Receives Consensus Rating of "Reduce" from Analysts
Shares of Baxter International Inc. (NYSE:BAX - Get Free Report) have been given a consensus rating of "Reduce" by the fourteen analysts that are covering the stock, MarketBeat.com reports. Three...
MarketBeat·11d ago
News Placeholder
Baxter International (NYSE:BAX) Stock Rating Lowered by Zacks Research
Zacks Research downgraded Baxter International from a "hold" rating to a "strong sell" rating in a report on Tuesday...
MarketBeat·12d ago
News Placeholder
Zacks Research Brokers Decrease Earnings Estimates for BAX
Baxter International Inc. (NYSE:BAX - Free Report) - Stock analysts at Zacks Research cut their Q3 2026 earnings estimates for shares of Baxter International in a research note issued to investors on...
MarketBeat·12d ago
News Placeholder
Baxter to Host Fourth-Quarter 2025 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its fourth-quarter 2025 financial results on Thursday, February 12, 2026 at 7:30 a.m...
Business Wire·13d ago
<
1
2
...
>

Latest BAX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.